Illumina Inc. and the Children's Hospital of Eastern Ontario Announce Research Collaboration.
Illumina Inc. and the Children's Hospital of Eastern Ontario (CHEO) announced a research collaboration to develop molecular diagnostic tests to screen newborn babies for spinal muscular atrophy (SMA) and hemoglobinopathies. These genetic diseases can lead to fatal health conditions, but can be managed and even prevented if caught at birth.
